Nipro Corp is a leading company globally, known for its strong corporate philosophy and values. The company represents a commitment to innovation, quality, and sustainability in the healthcare industry. Nipro Corp aims to enhance patients' lives through advanced medical technologies, including dialysis products, medical devices, and pharmaceuticals. With a focus on patient-centric care, Nipro Corp strives to ensure the highest standards of safety, effectiveness, and affordability in their products. The company's core values emphasize integrity, teamwork, and social responsibility. Nipro Corp continuously endeavors to contribute to society and improve healthcare outcomes worldwide.

Nipro Corp is primarily present in various countries and regions across the globe. The company has a strong international presence, with its main operations centered in Japan, its home country. Additionally, Nipro Corp actively conducts business in North America, Europe, Asia, and other parts of the world. With a diversified geographical reach, Nipro Corp aims to serve a wide range of customers and expand its market presence globally.

Nipro Corp, a renowned company, has achieved several significant milestones throughout its history. The company has successfully established a global presence in the healthcare industry through its innovative solutions and dedication to excellence. Nipro Corp has made key advancements in the development of medical devices, pharmaceuticals, and renal products, positioning itself as a leader in these sectors. Furthermore, Nipro Corp has achieved notable accomplishments in expanding its market reach, enhancing its product portfolio, and fostering strategic collaborations. The company's commitment to continual growth and improvement has enabled it to leave a lasting impact on the healthcare field, making it a trusted and respected name in the industry.

Nipro Corp is a leading Japanese company in the healthcare sector. Founded in 1954, it has a rich history and strong background. Nipro Corp initially started as a manufacturer of medical devices, specializing in hypodermic needles and syringes. Over the years, the company expanded its product portfolio to include a wide range of medical equipment, pharmaceuticals, and renal products. Nipro Corp has established itself as a global player, serving healthcare professionals and patients worldwide. With a commitment to innovation and quality, Nipro Corp continues to contribute to the advancement of healthcare technologies and improve the lives of people globally.

The main competitors of Nipro Corp in the market include Medtronic, Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, and Fresenius Medical Care.

Nipro Corp is primarily active in the healthcare industry.

Nipro Corp, a leading Japanese company, operates in the healthcare industry, focusing on medical equipment and pharmaceutical products. With a diverse business model, Nipro Corp manufactures and sells various medical devices, including renal and infusion solutions, blood purification systems, and diabetes care products. Their pharmaceutical division is involved in the development and sales of generic drugs and therapeutic pharmaceuticals. Through strategic partnerships and acquisitions, Nipro Corp continues to expand its global presence and enhance its product offerings. As a renowned healthcare company, Nipro Corp remains committed to improving patient outcomes and contributing to the advancement of medical science worldwide.

Det Nipro P/E-forhold er 20,99.

Nipro KUV er 0,40.

AlleAktien Kvalitetsscore for Nipro er 5/10.

Den Nipro omsætning er 586,79 mia. JPY.

Den Nipro indtjening er 11,11 mia. JPY.

The Nipro Corporation is a Japanese company that operates in various industries. Founded in 1954, the company has become a global player, offering a wide range of products and services. One of the company's main activities is the manufacturing of medical products. Thanks to advanced technology and extensive research and development, Nipro is able to offer its customers a variety of high-quality products that are used in both clinical and home environments. Nipro's medical products include infusion and dialysis devices, insulin pumps and injectors, blood glucose meters, catheters, stents, and other medical devices. Additionally, the company also offers a wide range of pharmaceutical products used to treat various diseases and ailments. In addition to healthcare, Nipro is also involved in other industries. For example, the company has a division for electronics products, including touchscreens, LED lighting technology, and energy storage systems. Here too, the company strives to develop innovative technologies and offer its customers high-quality products. Nipro is also active in the food industry, offering a wide range of natural foods and beverages. The company places special emphasis on sustainability and environmental friendliness, employing organic farming methods and resource-efficient production processes. Another important area for Nipro is environmental technology. The company develops and produces photovoltaic modules to harness renewable energies and water purification systems that enable sustainable water usage. In addition to product manufacturing, Nipro also provides consulting services to customers in various industries. The company supports its customers in the development of new products or services and helps optimize business processes. Overall, Nipro's business model is highly diversified, encompassing various industries and divisions. The company is committed to developing innovative technologies and offering its customers high-quality products and services. It also emphasizes sustainability and environmental friendliness, taking its responsibility towards society and the environment seriously.

Nipro udbetaler et udbytte på 26,00 JPY fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Nipro, eller selskabet udbetaler ikke udbytte.

ISIN'en for Nipro er JP3673600007.

WKN for Nipro er 875746.

Tickeren for Nipro er 8086.T.

I løbet af de sidste 12 måneder betalte Nipro en dividende på 27,00 JPY . Dette svarer til et dividendeudbytte på omkring 2,13 %. For de kommende 12 måneder vil Nipro sandsynligvis betale en dividende på 28,29 JPY.

Udbytteafkastet for Nipro er i øjeblikket 2,13 %.

Nipro betaler kvartalsvis udbytte. Dette uddeles i månederne oktober, april, oktober, april.

Nipro betalte udbytte hvert år i løbet af de sidste 23 år.

For de kommende 12 måneder forventes der dividender på 28,29 JPY. Dette svarer til et dividendeafkast på 2,20 %.

Nipro bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Nipro fra den 1.12.2024 på 12 JPY, skulle du have haft aktien i din portefølje før ex-datoen den 27.9.2024.

Udbetalingen af det sidste udbytte blev foretaget den 1.12.2024.

I løbet af 2023 udbetalte Nipro 18,5 JPY i form af dividender.

Udbytterne fra Nipro udbetales i JPY.